Codes / ICD10CM / L40.1

L40.1 Generalized pustular psoriasis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Generalized Pustular Psoriasis
  • A severe form of psoriasis marked by widespread pustules and systemic inflammation.

Summary

Generalized pustular psoriasis is a rare, acute-onset skin condition characterized by widespread sterile pustules, fever, and systemic symptoms. It is a medical emergency requiring prompt intervention due to potential complications like dehydration, infection, or organ dysfunction. The condition often follows triggers such as medication changes, infections, or pregnancy.

Causes

The exact cause is unknown, but it is linked to dysregulated immune responses and genetic predisposition. Triggers include abrupt withdrawal of systemic corticosteroids, certain medications (e.g., lithium, antimalarials), infections, or pregnancy (in the case of impetigo herpetiformis). Autoimmune mechanisms drive the rapid proliferation of neutrophils in the skin.

Risk Factors

  • Genetic predisposition: Family history of psoriasis or pustular variants.
  • Medication triggers: Sudden discontinuation of systemic therapies or use of specific drugs.
  • Infections: Bacterial or viral infections may precipitate episodes.
  • Pregnancy: Impetigo herpetiformis is a pregnancy-associated form.
  • Underlying psoriasis: Pre-existing plaque psoriasis increases risk.

Symptoms

  • Widespread erythema with sheets of non-follicular pustules.
  • Fever, chills, and malaise.
  • Painful skin, often with burning or stinging.
  • Possible mucosal involvement (e.g., oral or genital ulcers).
  • Rapid onset over hours to days.

Diagnosis

Diagnosis is clinical, based on history, physical exam, and exclusion of mimics (e.g., bacterial pustulosis, drug reactions). Labs may show leukocytosis, elevated inflammatory markers, or electrolyte imbalances. Skin biopsy confirms sterile pustules and neutrophilic infiltration. Imaging or organ function tests assess systemic involvement.

Treatment Options

  • Hospitalization: For severe cases to manage fluid/electrolyte balance and monitor complications.
  • Systemic therapies: Cyclosporine, acitretin, or biologics (e.g., IL-17 inhibitors) for rapid control.
  • Supportive care: Antipyretics, hydration, and skin barrier protection.
  • Trigger avoidance: Discontinuing inciting medications or treating infections.

Prognosis and Follow-Up

Prognosis depends on early treatment and underlying triggers. Untreated, it can progress to sepsis or organ failure. Long-term management focuses on trigger avoidance and maintenance therapy. Follow-up includes regular skin exams and monitoring for relapse or complications.

Complications

  • Sepsis or systemic infection from broken skin.
  • Dehydration and electrolyte imbalances due to fluid loss.
  • Acute respiratory distress syndrome (ARDS) in severe cases.
  • Renal or hepatic dysfunction from systemic inflammation.
  • Post-inflammatory hyperpigmentation after resolution.

Lifestyle & Prevention

  • Trigger avoidance: Identify and avoid medications or exposures that precipitate episodes.
  • Skin care: Gentle cleansing and moisturizing to prevent secondary infection.
  • Stress management: Stress may exacerbate flares; relaxation techniques may help.
  • Pregnancy planning: Close monitoring if pregnancy is a trigger.

When to Seek Professional Help

Seek immediate care for widespread pustules, fever, or systemic symptoms (e.g., chills, fatigue). Emergency evaluation is critical if signs of dehydration, confusion, or organ dysfunction appear.

Tips for Medical Coders

Document the extent of pustular involvement, triggers (if known), and systemic symptoms to support code assignment. Include details on treatment setting (inpatient vs. outpatient) and any complications. Ensure documentation aligns with clinical findings to justify the severity and acuity of the condition.

Medical Policies and Guidelines

Related policies from health plans

Spevigo (spesolimab-sbzo)
Spevigo (spesolimab-sbzo)
Stelara (ustekinumab)
Book a walkthrough

L40.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.